Search…

Lates News

22/09/2025

The CEO of Xilan Pharmaceuticals stated that they will consider adopting a direct-to-patient sales model for their weight loss drugs that are still in the trial phase, mentioning the changing dynamics of the obesity market.

Latest

3 m ago

TATA Health (01255.HK) releases mid-year performance report for 2024, with a net loss attributable to shareholders of 5.13 million Hong Kong dollars, a 58.38% decrease compared to the same period last year.

3 m ago

Market news: Iraq and oil companies are preparing to sign an agreement to restart exports from the Kurdish region.

3 m ago

Pfizer Inc. rose 2.1% in early trading. It is reported that Pfizer Inc. is set to acquire weight loss drug manufacturer Metsera for $7.3 billion. The deal values Metsera at $47.50 per share, with an additional $22.50 linked to performance milestones, representing a 42.5% premium to its latest closing price. This acquisition aligns with Pfizer's strategy to expand its product portfolio in the growing weight loss drug market.

3 m ago

Pfizer (PFE) rose 21.1% in early trading. It is reported that Pfizer is set to acquire weight loss drug manufacturer Metsera (MTSR) for $7.3 billion. The deal values Metsera at $47.50 per share, with an additional $22.50 linked to performance milestones, representing a 42.5% premium to its latest closing price. This acquisition aligns with Pfizer's strategic goal of expanding its product portfolio in the growing weight loss drug market.

4 m ago

The stock price of GameStop has reached a three and a half month high, rising 4.4% most recently.

+852 - 60190728

Customer Support

Commercial Services